申请人:Bristol-Myers Squibb Company
公开号:US06297233B1
公开(公告)日:2001-10-02
Caprolactam inhibitors are provided which have the structure
including pharmaceutically acceptable salts thereof and all stereoisomers thereof, and prodrugs thereof, wherein n is 1 to 5; and
and Y R1, R2, R3, R5, R5a, R6, R7, R8, R9 and R10 are as defined herein. These compounds are inhibitors of Factor Xa and thus are useful as anticoagulants. A method for treating cardiovascular diseases associated with thromboses is also provided.
提供了具有以下结构的己内酰胺抑制剂,包括其药用可接受的盐和所有立体异构体,以及其前药,其中n为1到5;并且Y,R1,R2,R3,R5,R5a,R6,R7,R8,R9和R10如本文所定义。这些化合物是因子Xa的抑制剂,因此可用作抗凝剂。还提供了一种治疗与血栓有关的心血管疾病的方法。